Switch to:
More From Other Websites
The Most Notable Abstracts Released Ahead Of ASCO 2017 May 19 2017
Today's Research Reports on Biotech Stocks to Watch: Achillion Pharmaceuticals and CytRx May 19 2017
CytRx to Present Global Phase 3 Aldoxorubicin Clinical Data in Patients with Soft Tissue Sarcomas at... May 17 2017
CytRx reports 1Q loss May 10 2017
CytRx Reports First Quarter 2017 Financial Results May 10 2017
CytRx Corporation Announces Pricing of $15 Million Public Offering of Common Stock Apr 28 2017
CytRx Corporation Announces Proposed Public Offering of Common Stock Apr 27 2017
Penny Stocks to Watch for May 2017 Apr 27 2017
CytRx to Present Aldoxorubicin Clinical Trial Data in Patients with Soft Tissue Sarcomas at the 2017... Apr 21 2017
CytRx Gets Clarity from FDA for Aldoxorubicin NDA, Shares Up Apr 20 2017
ETFs with exposure to CytRx Corp. : April 20, 2017 Apr 20 2017
Blog Coverage CytRx Announces FDA's Approval for New Drug Application Apr 20 2017
CytRx Announces FDA Agreement on Regulatory Pathway to Approval for Aldoxorubicin in Soft Tissue... Apr 19 2017
For These Small-Cap Biotech CEOs, Stock Promotion, Not Drug Development, Was Priority No. 1 Apr 11 2017
CytRx Corp. :CYTR-US: Earnings Analysis: Q4, 2016 By the Numbers : March 21, 2017 Mar 21 2017
CytRx Reports 2016 Financial Results Mar 15 2017
The 'Gnarly 9' Biotechs Will Test the FDA's Mettle Mar 08 2017
CytRx to Present at the 29th Annual ROTH Conference Mar 07 2017
CytRx to Present at the 19th Annual BIO CEO & Investor Conference Feb 06 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

FEEDBACK